Spike-specific antibodies are central to effective COVID19 immunity. Research efforts have focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing antibodies. Anti

NIAID Data Ecosystem50

Data from in vitro protocols using THP-1

冠状病毒免疫反应

药物筛选研究

Data from in vitro protocols using THP-1 cells exposed to SARS-Cov-2 inactivated virus and paclitaxel

科学数据银行2024-03-05 更新20

Comparison of IgG antibodies to SARS-CoV-2 spike and RBD proteins in December 2020 and February 2021.

冠状病毒免疫反应

抗体动态分析

Comparison of IgG antibodies to SARS-CoV-2 spike and RBD proteins in December 2020 and February 2021.

NIAID Data Ecosystem70

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

T细胞交叉反应性

冠状病毒免疫反应

We used the viral functional expansion of specific T cells (ViraFEST) platform to identify T cell responses crossreactive for the spike (S) glycoproteins of SARS-CoV-2 and common cold coronaviruses (C

Immunology Database and Analysis Portal2025-10-30 更新20

Cross neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2

资源简介：

相关数据集